Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
OHE Lunchtime Seminar on 14 December 2015: From the Antipodes to the Motherland: Reflections on HTA Decision Makers as Budget Takers and Budget Makers
13 November 2015
OHE’s Deputy Director Paula Lorgelly will present an OHE Seminar on 14th December 2015 on the topic of HTA decision makers as budget takers and budget…
Valuing Health at the End of Life: A Review of the Empirical Literature
3 November 2015
Do members of the general public wish to place greater weight on a unit of health gain for end of life patients than on that for…
OHE at ISPOR Latin America: Policy Options for Formulary Development in Middle-income Countries
20 October 2015
This post summarises OHE’s activities at this year’s ISPOR Latin America conference in Santiago, September 2015. Topics include policy options for formulary development in middle-income countries,…
Government and Charity Funding of Cancer Research: Public Preferences and Choices
13 October 2015
How might a change in government spending on cancer research affect the public’s willingness to donate to cancer research charities?
Recently Published: Local Health Care Expenditure Plans and their Opportunity Costs
8 September 2015
Recently published in Health Policy is an article by Sarah Karlsberg Schaffer, Jon Sussex, Nancy Devlin and Andrew Walker entitled “Local health care expenditure plans and…
Recently Published: Payer Perspectives on Future Acceptability of Comparative Effectiveness and Relative Effectiveness Research
18 August 2015
This paper examines the views of US and European payers on the rapidly evolving fields of comparative effectiveness and relative effectiveness research.
An Issues Panel: Developing Cost Effectiveness for Decision Making: What can be Learnt from “Value Based Pricing”?
29 July 2015
This post reports on an Issues Panel which was held at the Spanish Health Economics Association Annual Conference which took place in Granada, Spain 17-19 June…
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
This post summarises OHE’s activities at this year HTAi meeting in Oslo, June 2015. Topics include the effect of NICE decisions abroad and a new drug…
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
This post summarises OHE’s activities at the upcoming HTAi meeting in Oslo, June 2015. Topics include the effect of NICE decisions abroad, a framework for developing…